Range Impact, Inc. (RNGE)

OTCMKTS · Delayed Price · Currency is USD

0.1700

-0.0250 (-12.82%)

At close: Apr 15, 2026

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
Corporate	1.00M		-	-					-	-
Range Land	2.71M		-	-					-	-
Range Security	-		684.20K	-					-	-
Range Reclaim	-		18.66M	4.83M					-	-
Range Reclaim Growth	-		286.20%	-					-	-
Pharmaceutical Operations	-		-	-					102.42K	163.36K
Pharmaceutical Operations Growth	-		-	-					-37.31%	-34.22%
Total	3.71M		19.35M	4.83M					102.42K	163.36K
Total Growth	-		300.36%	-					-37.31%	-34.22%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
United States	3.71M		19.35M	4.83M					102.42K	163.36K
United States Growth	-		300.36%	-					-37.31%	-34.22%
Total	3.71M		19.35M	4.83M					102.42K	163.36K
Total Growth	-		300.36%	-					-37.31%	-34.22%

Source: S&P Global Market Intelligence.